August 23, 2025

Trade and Tariff Update with Aug. 1 Nearing

By Joe Lieber

Before we get to our analysis below, we are hosting a trade conference call tentatively set for 11:00 am ET next Wednesday, July 30 with a leading trade specialist, Derek Scissors. Look for a conference…

Read More >>

August 21, 2025

Bureau of Labor Statistics: Can Investors Trust the Numbers Conference Call Takeaways

By Joe Lieber

We hosted former Bureau of Labor Statistics (BLS) commissioner Bill Beach on a conference call yesterday to discuss the recent firing of Erika McEntarfer, President Trump’s new candidate for the position, and whether investors can…

Read More >>

August 18, 2025

[CVS, CI, UNH, ELV]: CA’s PBM Reform Bill Appears Next Up in PBM Fight

By Beth Steindecker

With California’s legislature coming back Monday from its summer recess for its final few weeks of the regular session, pharmacy benefit manager (PBM) legislation is still on the docket and likely to invite headline risk…

Read More >>

August 13, 2025

Senate 2026 Election Preview

By Joe Lieber

We think the Senate is likely to remain in Republican hands after the 2026 mid-term elections, though with GOP at risk for losing seats, which could have implications for financial markets. We continue to view…

Read More >>

August 13, 2025

[PNTG, EHAB, BTSG, ADUS, AMED, AVAH, UNH]: Where Might CMS Go with Home Health Rates?

By Beth Steindecker

With slightly more than two weeks left in CMS’s comment period for the CY26 Medicare reimbursement proposal rule for home health [PNTG, EHAB, BTSG, ADUS, AVAH, AMED, UNH], we continue to expect mitigation from CMS’s…

Read More >>

August 12, 2025

Rx Most Favored Nation Company Risks

By John Leppard

With President Trump demanding “binding commitments” from drug manufacturers to offer Most Favored Nation (MFN) pricing by Sept. 29, we outline company-specific revenue risks and our expectations for an eventual regulatory proposal in 4Q25 /…

Read More >>

August 8, 2025

Stephen Miran Can Be Confirmed before the Next Fed Meeting

By Joe Lieber

In our view, if President Trump insist, we believe that Stephen Miran can be confirmed by the Senate before the September 17 Federal Open Market Committee (FOMC) meeting. While the market already anticipates that the…

Read More >>

August 7, 2025

House 2026 Election Preview

By Joe Lieber

While we are a more than a year away from the mid-term elections, we offer our early view about which party might control the House after next November. Our bottom line: we expect the House…

Read More >>

August 7, 2025

Health Insurer / Provider Legislative Agenda: Band-Aid Likely in September CR, More Substantial Package Potentially Later in the Year

By Beth Steindecker

With the August recess in full swing for the next few weeks, the various healthcare-related legislative items on Congress’s to-do list (see below) remains lengthy for the rest of the calendar year. We are still…

Read More >>

August 5, 2025

Trade and Tariff Update: Unpacking Trump’s Comments

By Joe Lieber

We have the following takeaways on trade and tariffs regarding President Trump’s interview on CNBC this morning. While Trump mentioned that he would raise tariffs on India over the next 24 hours since India continues…

Read More >>

August 3, 2025

Hospices, IRFs, IPFs: Thoughts on Final FY26 Medicare Payment Rules

By Beth Steindecker

Medicare’s final FY26 payment regulations for hospices [CHE, AMED, ADUS, PNTG, BTSG, Gentiva, Compassus, Elara], inpatient rehab facilities (IRFs) [EHC, SEM], and inpatient psych facilities (IPFs) [UHS, ACHC] aligned with expectations for: 1) slightly higher aggregate spending…

Read More >>

August 1, 2025

Hospitals, LTCHs, SNFs: Thoughts on Medicare’s Final FY26 Inpatient Rate Rules

By Beth Steindecker

Medicare’s final FY26 payment regulations for inpatient hospitals [HCA, THC, CYH, ARDT, UHS, MPW, municipal bond-backed facilities], long-term care hospitals (LTCHs) [SEM, Kindred], and skilled nursing facilities (SNFs) [ENSG, PACS, Providence] with implications for their post-acute…

Read More >>

July 31, 2025

Trade and Tariff Conference Call Takeaways

By Joe Lieber

With the August 1 tariff deadline tomorrow, we have the following takeaways from our trade and tariff conference call that we held yesterday morning with Derek Scissors. A transcript is available upon request. Takeaways Derek…

Read More >>

July 31, 2025

The State of Biopharma, Tools, & Research Spending

By John Leppard

This morning’s Senate Appropriations Committee’s markup of the FY26 Labor / HHS funding bill, which includes a $400M increase (+0.8% YoY) for NIH, should serve as an interim clearing event for life science tools (LST)…

Read More >>

July 30, 2025

HUM: MA Stars Lawsuit May Provide Another Boost to HUM, Timing Unknown

By Beth Steindecker

Against the backdrop of positive Q2 earnings, upward full-year guidance, and voiced confidence in the ability to manage the medical cost and utilization trends throughout 2H and into next year, we think the recently refiled…

Read More >>